Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. (Q53144473)
Jump to navigation
Jump to search
scientific article published on 5 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. |
scientific article published on 5 October 2011 |
Statements
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. (English)
1 reference
1 reference
1 reference
A Ferrero
1 reference
G De Rauglaudre
1 reference
P Vasey
1 reference
A Reinthaller
1 reference
E Pujade-Lauraine
1 reference
N Reed
1 reference
S Siena
1 reference
H Helland
1 reference
L Elit
1 reference
S Mahner
1 reference
5 October 2011
1 reference
23
1 reference
5
1 reference
1185-1189
1 reference
Identifiers
1 reference